KRAS mutations are the earliest events found in approximately 90% of pancreatic ductal adenocarcinomas (PDACs). However, little is known as to why KRAS mutations preferentially occur in PDACs and what processes/factors generate these mutations. While abnormal carbohydrate metabolism is associated with a high risk of pancreatic cancer, it remains elusive whether a direct relationship between KRAS mutations and sugar metabolism exists. Here, we show that under high-glucose conditions, cellular O-GlcNAcylation is significantly elevated in pancreatic cells that exhibit lower phosphofructokinase (PFK) activity than other cell types. This post-translational modification specifically compromises the ribonucleotide reductase (RNR) activity, leading to deficiency in dNTP pools, genomic DNA alterations with KRAS mutations, and cellular transformation. These results establish a mechanistic link between a perturbed sugar metabolism and genomic instability that induces de novo oncogenic KRAS mutations preferentially in pancreatic cells.
Pubmed ID: 30853214 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.
View all literature mentionsThis monoclonal targets Histone H2A.X, phospho (Ser139)
View all literature mentionsThis monoclonal targets O-GlcNAc (CTD110.6) Mouse mAb
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets beta Actin
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis polyclonal targets PFKP
View all literature mentionsThis monoclonal targets Nuclear Matrix Protein p84
View all literature mentionsThis polyclonal targets mCherry
View all literature mentionsThis monoclonal targets 6X His tag
View all literature mentionsThis polyclonal targets Fructose 6 Phosphate Kinase
View all literature mentionsThis polyclonal targets PFKL
View all literature mentionsThis unknown targets O-GlcNAc Transferase
View all literature mentionsThis monoclonal targets GFAT1 (H-49)
View all literature mentionsThis polyclonal targets RRM1
View all literature mentionsThis monoclonal targets 53BP1 clone BP13
View all literature mentionsThis monoclonal targets Histone H2A.X pSer139
View all literature mentionsThis polyclonal targets Pan-Ras Asp12 (Ab-1) Rabbit pAb
View all literature mentionsThis monoclonal targets p53R2
View all literature mentionsThis polyclonal targets SGLT2
View all literature mentionsThis monoclonal targets O-Linked N-Acetylglucosamine
View all literature mentionsThis polyclonal targets GLUT2
View all literature mentionsThis polyclonal targets GLUT1
View all literature mentionsCell line Hs 68 is a Finite cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line hTERT-HPNE is a Telomerase immortalized cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line NL20 is a Transformed cell line with a species of origin Homo sapiens
View all literature mentionsCell line H184B5F5/M10 is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line MCF-10A is a Spontaneously immortalized cell line with a species of origin Homo sapiens
View all literature mentionsCell line NCM356 is a Spontaneously immortalized cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line Hs 68 is a Finite cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line MCF-10A is a Spontaneously immortalized cell line with a species of origin Homo sapiens
View all literature mentions